Captrust Financial Advisors Relay Therapeutics, Inc. Transaction History

Captrust Financial Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$13.31 - $34.88 $173 - $453	13 New	13 $0
Q1 2022 May 16, 2022	SELL	$20.26 - $32.36 $202 - $323	-10 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$26.0 - $37.03 $260 - $370	10 New	10 $0
Q3 2021 Nov 16, 2021	SELL	$29.75 - $37.99 $208 - $265	-7 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$27.5 - $38.19 $192 - $267	7 New	7 $0

203

156M

207K

40K

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $588M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.